Search

everythinglearnresearchcommunity

for

Search:↓

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Focal atrichia helps diagnose female pattern hair loss.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Granulomatous alopecia may be a distinct subtype of alopecia areata.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

Unilateral keratosis follicularis squamosa may be a new subtype, successfully treated with asiaticoside ointment.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

People with TED often have low B12 levels and might benefit from B12 supplements.

Alopecia areata incognita causes sudden hair loss but usually improves with topical steroids.

Different types of hair loss within Telogen Effluvium are caused by various disruptions in hair growth cycles.

Four new cases confirmed the unique features of follicular porokeratosis.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Better diagnostic tools and treatment guidelines are needed for segmental vitiligo and related pigment issues.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

TGF-β1 and 2 may play a role in hair loss in AGA.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

TSH levels are similar across nonscarring alopecia types, with unclear racial differences.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.